Department of Genetics, Dartmouth Medical School, Lebanon, New Hampshire 03756, USA.
Anal Chem. 2011 Oct 15;83(20):7635-44. doi: 10.1021/ac201894j. Epub 2011 Sep 20.
Reversible protein phosphorylation is an essential regulatory component of virtually every cellular process and is frequently dysregulated in cancer. However, significant analytical barriers persist that hamper the routine application of phosphoproteomics in translational settings. Here, we present a straightforward and reproducible approach for the broadscale analysis of protein phosphorylation that relies on a single phosphopeptide enrichment step using titanium dioxide microspheres from whole cell lysate digests and compared it to the well-established SCX-TiO(2) workflow for phosphopeptide purification on a proteome-wide scale. We demonstrate the scaleabilty of our approach from 200 μg to 5 mg of total NCI-H23 non-small cell lung adenocarcinoma cell lysate digest and determine its quantitative reproducibility by label-free analysis of phosphopeptide peak areas from replicate purifications (median CV: 20% RSD). Finally, we combine this approach with immunoaffinity phosphotyrosine enrichment, enabling the identification of 3168 unique nonredundant phosphotyrosine peptides in two LC-MS/MS runs from 8 mg of HeLa peptides, each with 80% phosphotyrosine selectivity, at a peptide FDR of 0.2%. Taken together, we establish and validate a robust approach for proteome-wide phosphorylation analysis in a variety of scenarios that is easy to implement in biomedical research and translational settings.
蛋白质可逆磷酸化是几乎所有细胞过程的基本调节成分,并且在癌症中经常失调。然而,仍然存在显著的分析障碍,阻碍了磷酸蛋白质组学在转化环境中的常规应用。在这里,我们提出了一种简单且可重复的方法,用于广泛分析蛋白质磷酸化,该方法依赖于使用 TiO2 微球从整个细胞裂解物消化物中进行单一磷酸肽富集步骤,并将其与广泛用于全蛋白质组范围内磷酸肽纯化的 SCX-TiO2 工作流程进行了比较。我们展示了从 200μg 到 5mg 的 NCI-H23 非小细胞肺腺癌细胞裂解物消化物的方法的可扩展性,并通过从重复纯化的磷酸肽峰面积进行无标记分析来确定其定量重现性(中位数 CV:20%RSD)。最后,我们将这种方法与免疫亲和磷酸酪氨酸富集相结合,使我们能够在两个 LC-MS/MS 运行中鉴定出 3168 个独特的非冗余磷酸酪氨酸肽,每个肽具有 80%的磷酸酪氨酸选择性,肽 FDR 为 0.2%。总之,我们建立并验证了一种在各种情况下进行全蛋白质组磷酸化分析的稳健方法,该方法易于在生物医学研究和转化环境中实施。